Group I Metabotropic Glutamate Receptor Signalling and its Implication in Neurological Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 5, 2010-11 ,pp. : 574-595

Bentham Science Publishers

Access to resources Recommend Favorite

Group I metabotropic glutamate receptors modulate glutamate and -aminobutyric acid release in the periaqueductal grey of rats

By de Novellis V.   Marabese I.   Palazzo E.   Rossi F.   Berrino L.   Rodella L.   Bianchi R.   Rossi F.   Maione S.  

European Journal of Pharmacology, Vol. 462, Iss. 1, 2003-02 ,pp. : 73-81

Elsevier

Access to resources Recommend Favorite

Therapeutic Potential of Group III Metabotropic Glutamate Receptors

By  

Current Medicinal Chemistry, Vol. 15, Iss. 7, 2008-01 ,pp. : 671-684

Bentham Science Publishers

Access to resources Recommend Favorite

Selective activation of group-II metabotropic glutamate receptors is protective against excitotoxic neuronal death

By Battaglia G.   Bruno V.   Ngomba R.T.   Di Grezia R.   Copani A.   Nicoletti F.  

European Journal of Pharmacology, Vol. 356, Iss. 2, 1998-09 ,pp. : 271-274

Elsevier

Access to resources Recommend Favorite

Different effects of NMDA/group I metabotropic glutamate receptor agents in - and -opioid receptor agonist-induced supraspinal antinociception

By Suzuki T.   Aoki T.   Ohnishi O.   Nagase H.   Narita M.  

European Journal of Pharmacology, Vol. 396, Iss. 1, 2000-05 ,pp. : 23-28

Elsevier

Access to resources Recommend Favorite